Innoviva Specialty Therapeutics

Innoviva Specialty Therapeutics, Inc. a subsidiary of Innoviva, Inc. (NASDAQ: INVA), is a Boston-based biopharmaceutical company dedicated to advancing care for patients facing serious infectious diseases and life-threatening conditions in critical care settings. The company develops and commercializes differentiated, hospital-focused therapies that address urgent and often difficult-to-treat unmet medical needs, including four FDA-approved antimicrobial agents and a novel vasopressor for patients with septic or other distributive shock. Through its expanding portfolio, Innoviva Specialty Therapeutics plays a vital role in improving outcomes for some of the most vulnerable patient populations. Learn more at www.innovivaspecialtytherapeutics.com.